Kallikrein 7 (KLK7) (Middle Region) Peptide
KLK7
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all Kallikrein 7 (KLK7) products
- Kallikrein 7 (KLK7)
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- IKASKSFRHP GYSTQTHVND LMLVKLNSQA RLSSMVKKVR LPSRCEPPGT
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-KLK7 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Kallikrein 7 (KLK7)
- Synonyms
- Prss6 Peptide, SCCE Peptide, PRSS6 Peptide, hK7 Peptide, kallikrein related-peptidase 7 (chymotryptic, stratum corneum) Peptide, kallikrein-related peptidase 7 Peptide, kallikrein related peptidase 7 Peptide, Klk7 Peptide, KLK7 Peptide
- Background
-
This gene encodes a member of the kallikrein subfamily of serine proteases. These enzymes have diverse physiological functions and many kallikrein genes are biomarkers for cancer. The encoded protein has chymotrypsin-like activity and plays a role in the proteolysis of intercellular cohesive structures that precedes desquamation, the shedding of the outermost layer of the epidermis. The encoded protein may play a role in cancer invasion and metastasis, and increased expression of this gene is associated with unfavorable prognosis and progression of several types of cancer. Polymorphisms in this gene may play a role in the development of atopic dermatitis.
Protein Size: 181 - Gene ID
- 5650
-
You are here:
